• 首页
  • 投资者关系
  • 信息披露
  • 社会责任
  • 广药动态
  • English
财务指标股本状况流通股东 治理结构 股东回报情况公平在身边投资者保护宣传
定期报告临时公告
社会责任共享健康权利共建透明商业共绘绿水青山共铸发展基石我们的故事社会责任暨ESG报告
About UsFinancial HighlightsShare CapitalShareholdersDistribution PlanRegular ReportCSR(社会责任)CSR & ESG Report
  • About Us
  • Financial Highlights
  • Share Capital
  • Shareholders
  • Distribution Plan
  • Regular Report
  • CSR(社会责任)
  • CSR & ESG Report

SUMMARY OF THE 2025 INTERIM REPORT

2025-08-16 14:12:40

2025 FIRST QUARTERLY REPORT

2025-04-30 10:28:57

Annual Report 2024

2025-04-11 16:36:42

SUMMARY OF THE 2024 ANNUAL REPORT

2025-03-14 11:05:57

SUMMARY OF THE 2024 INTERIM REPORT

2024-09-02 14:46:39

Annual Report 2023

2024-04-19 08:56:22

SUMMARY OF THE 2023 ANNUAL REPORT

2024-03-16 11:44:20

2023 THIRD QUARTERLY REPORT

2023-10-31 16:49:58

Interim Report 2023

2023-09-12 09:10:29

SUMMARY OF THE 2023 INTERIM REPORT

2023-08-19 09:23:30

Annual Report 2022

2023-04-14 09:25:33

SUMMARY OF THE 2022 ANNUAL REPORT

2023-03-18 14:56:23

2022 THIRD QUARTERLY REPORT

2022-10-26 01:11:24

Interim Report 2022

2022-09-14 01:10:18

2022 FIRST QUARTERLY REPORT

2022-04-26 02:03:40

关于我们    |    联系我们

电话:(8620)66281011    传真:(8620)66281229    地址:广州市荔湾区沙面北街45号

广州白云山医药集团股份有限公司 版权所有 Copyright © 2000-2020 gybys.com.cn, All Rights Reserved 粤ICP备13064121号